Flash FinanceUS
After hours S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Marsh McLennan (MRSH)

Marsh McLennan appoints Bruce Broussard to board and Audit Committee

Neutral Impact 2 of 5 leadership Written later

Marsh McLennan's board appointed Bruce Broussard as an independent director, effective immediately, and also named him to the Audit Committee. The company's press release says the board now has 12 directors, and Broussard is a former Humana CEO, which gives the board healthcare and insurance experience.

Key points

  • Appointment effective July 9, 2025, as an independent, non-management director
  • Broussard also joins the Audit Committee; the board determined he meets its independence requirements
  • Press release says Broussard was Humana's CEO from 2013 to 2024 and serves on the HP Inc., Cleveland Clinic and One Call boards
  • Board now consists of 12 directors, per the press release

The filing

CompanyMarsh McLennan (MRSH)
Form8-K, current report
Filed with the SECJul 9, 2025, 4:01 PM ET
Accession number0000062709-25-000057

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:21 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 09, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.